News
A Glimpse Into The Expert Outlook On Integra Lifesciences Through 8 Analysts
7 May 24
Analyst Ratings
Morgan Stanley Maintains Underweight on Integra Lifesciences, Lowers Price Target to $24
7 May 24
News, Price Target, Analyst Ratings
JMP Securities Maintains Market Outperform on Integra Lifesciences, Lowers Price Target to $40
7 May 24
News, Price Target, Analyst Ratings
Wells Fargo Downgrades Integra Lifesciences to Equal-Weight, Lowers Price Target to $25
7 May 24
News, Downgrades, Price Target, Analyst Ratings
Truist Securities Maintains Hold on Integra Lifesciences, Lowers Price Target to $25
7 May 24
News, Price Target, Analyst Ratings
B of A Securities Maintains Underperform on Integra Lifesciences, Lowers Price Target to $26
7 May 24
News, Price Target, Analyst Ratings
Stocks On Track For Third Green Session, Palantir Ignites Rally In Chipmakers, Commodities Rebound: What's Driving Markets Monday?
6 May 24
Cryptocurrency, Equities, Large Cap, Market Summary, Mid Cap, Sector ETFs, Broad U.S. Equity ETFs, Commodities, Small Cap, Global, Econ #s, Top Stories, Intraday Update, Tech, ETFs
Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday
6 May 24
News, Intraday Update, Markets, Movers, Trading Ideas
Why Perficient Shares Are Trading Higher By Around 53%? Here Are 20 Stocks Moving In Monday's Mid-Day Session
6 May 24
News, Intraday Update, Markets, Movers
12 Health Care Stocks Moving In Monday's Intraday Session
6 May 24
Movers
Why Is Medical Device Maker Integra LifeSciences Stock Falling On Monday?
6 May 24
Earnings, News, Guidance, Health Care, Top Stories, Movers, General
Integra LifeSciences Expects FY24 Revenue of $1.672B-$1.687B (Prior $1.603B-$1.618B) Vs $1.616B Est, Adj EPS of $3.01-$3.11 (Prior $3.15-$3.25) Vs $3.19 Est
6 May 24
News, Guidance
Integra LifeSciences Expects Q2 Revenue of $411M-$416M Vs $395.8M Est, Adj EPS of $0.60-$0.65 Vs $0.75 Est
6 May 24
News, Guidance
Integra LifeSciences To Spotlight CereLink Intracranial Pressure Monitoring System At The American Association Of Neurological Surgeons Annual Scientific Meeting
30 Apr 24
Biotech, News, General
Citigroup Upgrades Integra Lifesciences to Neutral, Maintains Price Target to $38
3 Apr 24
News, Upgrades, Price Target, Analyst Ratings
Integra LifeSciences Launches MicroMatrix Flex To Provide Convenient Access To Hard-To-Reach Areas In Complex Cases
11 Mar 24
Biotech, News, General
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In March
7 Mar 24
Long Ideas, News, Penny Stocks, Health Care, Small Cap, Pre-Market Outlook, Markets, Trading Ideas, General
Truist Securities Maintains Hold on Integra Lifesciences, Lowers Price Target to $41
1 Mar 24
News, Price Target, Analyst Ratings
Analyst Scoreboard: 5 Ratings For Integra Lifesciences
29 Feb 24
Analyst Ratings
JMP Securities Maintains Market Outperform on Integra Lifesciences, Lowers Price Target to $49
29 Feb 24
News, Price Target, Analyst Ratings
Press releases
Integra LifeSciences Reports First Quarter 2024 Financial Results
6 May 24
Earnings, Press Releases
Integra LifeSciences to Spotlight CereLink® Intracranial Pressure (ICP) Monitoring System at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting
30 Apr 24
News, Press Releases, General
Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024
18 Apr 24
Press Releases
Integra LifeSciences Completes the Acquisition of Acclarent, Inc.
1 Apr 24
M&A, News, Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Integra Lifesciences Holdings Corp - IART
27 Mar 24
News, Legal, Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Integra Lifesciences Holdings Corp - IART
25 Mar 24
Press Releases
Integra LifeSciences Launches MicroMatrix® Flex to Provide Convenient Access to Hard-to-Reach Areas in Complex Cases
11 Mar 24
Health Care, Press Releases, General
Integra LifeSciences Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance
28 Feb 24
Earnings, Press Releases
Integra LifeSciences Announces Leadership Transition Plan
28 Feb 24
News, Management, Press Releases
INVESTIGATION ALERT: Kaskela Law LLC Announces Shareholder Investigation of Integra LifeSciences Holdings Corp. (NASDAQ: IART) and Encourages Long-Term Investors to Contact the Firm
14 Feb 24
News, Legal, Press Releases